Clinical Trial Update: Bipolar Disorder Study for Men and Women [Phase 3]

View source ↗

Summary

Completed Phase 3 clinical trial evaluating a bipolar disorder treatment sponsored by GlaxoSmithKline. The study enrolled men and women and is now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Snippet

Sponsor: GlaxoSmithKline | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED